Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CardioTech sells catheter and disposables technology unit to Tacpro:

This article was originally published in Clinica

Executive Summary

CardioTech International has divested its catheter and disposables technology (CDT) subsidiary in line with its strategy to focus on biomaterials. Wilmington, Massachusetts-based CardioTech sold the CDT unit, which includes a manufacturing facility in Minnesota, for $1.2m to Tacpro, a firm specialising in catheters and delivery systems. Net of escrow funding and transaction costs, the proceeds for CardioTech are some $734,000. The purchase will allow Tacpro, of Campbell, California, to expand its operations into the US Midwest region, said the company's president and CEO Nitin Matani. Aside from its CDT business, the last 12 months have also seen CardioTech divest its Gish Biomedical subsidiary to German company Medos Medizintechnik (see Clinica No 1264, p 17). CardioTech has been sharpening its focus on its materials science business, which it believes is "low capital intensity and has the potential to grow rapidly and generate a stable licence-based revenue stream with attractive profitability".

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046646

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel